- Home
- The Firm
- Practice Areas
- Lawyer Directory
- Library
- Events / Seminars
- Recruitment
- Contact Us
- Resource Directory
THOMSON, ROGERS has issued a national Class Action lawsuit on behalf of people with Parkinson’s disease and/or Restless Leg Syndrome who allege to have developed compulsive behaviour, often including a pathological gambling addiction, as a result of their use of the drug Permax, a dopamine agonist. The Class Action seeks millions of dollars in compensation from the alleged makers and distributors of the drug and has named Eli Lilly Canada Inc., Eli Lilly & Company, Shire Biochem Inc., and Draxis Health Inc. as Defendants.
The representative plaintiff, Mr. Swapan Banerjee, from Mississauga, Ontario, alleges that he started gambling compulsively after he started taking Permax and lost more than $200,000.00. Many more Canadians are believed to have suffered a similar experience. Medical reports have linked the drug to compulsive behaviour, including pathological gambling.
If you would like to notify Health Canada of side effects you have experienced as a result of the use of Permax, please call the Health Canada Adverse Reporting Centre at their toll-free number, 1-866-234-2345.
If you’d like to learn more about this class action, please contact Darcy Merkur via e-mail or through our toll-free number 1-888-223-0448. Locally, in the Toronto area, you may call 416-868-3176.
If you are a user of Permax and wish to support the Class Action and be included in our Permax Class Action database, please complete the following information form.